We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
A comprehensive guide for Indian patients on understanding and managing the potential side effects of Lumakras (sotorasib), a medication used for non-small cell lung cancer.

Lumakras, with the generic name sotorasib, is a vital medication prescribed for adults diagnosed with a specific type of non-small cell lung cancer (NSCLC). It works by targeting a particular genetic mutation, KRAS G12C, which is found in some lung tumors. While Lumakras offers a new avenue for treatment, like all medications, it can come with side effects. This guide aims to provide clear, practical information for Indian patients about the potential side effects of Lumakras, how to manage them, and when to seek medical attention. Understanding these effects is crucial for effective treatment and maintaining overall well-being during therapy.
During treatment with Lumakras, patients may experience a range of side effects, from mild to more serious. It's important to remember that not everyone will experience these effects, and their severity can vary.
Several mild side effects have been reported in studies of Lumakras. These are often manageable and may resolve over time. If they persist or become bothersome, it is essential to discuss them with your doctor.
For most patients, these mild side effects are temporary. Your doctor or pharmacist can offer advice on managing these symptoms. It's important not to stop taking Lumakras without consulting your doctor first.
While less common, Lumakras can also lead to serious side effects that require immediate medical attention. Prompt recognition and action are key to managing these potentially severe reactions.
Managing side effects effectively is a crucial part of Lumakras treatment. Open communication with your healthcare team is paramount.
If you experience diarrhea, it's important to stay hydrated by drinking plenty of fluids, especially those containing electrolytes like oral rehydration solutions (ORS) or sports drinks. Your doctor might recommend over-the-counter medications like loperamide (Imodium A-D) to help control symptoms. If diarrhea is severe or doesn't improve with treatment, contact your doctor immediately. They may suggest pausing your Lumakras treatment temporarily.
Regular blood tests will be conducted to monitor your liver function throughout the treatment. If signs of liver damage appear, your doctor will take appropriate steps, which might include adjusting the dosage or temporarily stopping the medication.
For other side effects like swelling or digestive discomfort, your doctor can provide specific advice and potential treatments. Always report any new or worsening symptoms to your healthcare provider.
Certain side effects require urgent medical attention. Do not hesitate to seek help if you experience any of the following:
If you believe you are experiencing a life-threatening side effect or a medical emergency, call 911 or your local emergency number immediately.
In India, patients and healthcare professionals can report adverse drug reactions to the Central Drugs Standard Control Organization (CDSCO) through their Pharmacovigilance Programme of India (PvPI). Reporting helps in monitoring the safety of medicines and ensuring public health. You can also inform your doctor or pharmacist about any side effects you experience.
Lumakras (sotorasib) is an important treatment option for certain patients with non-small cell lung cancer. While side effects can occur, understanding them and knowing how to manage them can significantly improve the treatment experience. Maintaining open communication with your healthcare team, reporting any concerns promptly, and following medical advice are key to navigating treatment safely and effectively. This information is intended to supplement, not replace, the advice of your doctor. Always consult with your healthcare provider for any questions or concerns regarding your treatment.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026